Medicine Description apidra-solostar 100i
Apidra Solostar 100 IU 5 ml Insulin Pen is a medication that contains insulin glulisine, a rapid-acting insulin analog. Upon administration, insulin glulisine quickly binds to insulin receptors on the surface of target cells, facilitating the uptake of glucose from the bloodstream into muscle and adipose tissues. This action reduces blood glucose levels by promoting glycogen synthesis and inhibiting gluconeogenesis in the liver. Its rapid onset and short duration of action make it particularly effective for managing postprandial (after meal) hyperglycemia, as it mimics the physiological insulin response to carbohydrate intake.
Indications and Uses of Apidra Solostar 100 IU 5 ml Insulin Pen
- Management of hyperglycemia in patients with type 1 diabetes mellitus.
- Management of hyperglycemia in patients with type 2 diabetes mellitus.
- Control of postprandial blood glucose levels.
Side Effects of Apidra Solostar 100 IU 5 ml Insulin Pen
- Hypoglycemia (low blood sugar)
- Weight gain
- Injection site reactions (redness, swelling, itching)
- Allergic reactions (rare)
- Edema (swelling due to fluid retention)
Storage and Handling
Store Apidra Solostar pens in a refrigerator between 2°C to 8°C (36°F to 46°F) until they are opened. Once in use, the pens can be kept at room temperature (below 30°C or 86°F) for up to 28 days. Protect from light and do not freeze. Discard any pen that has been frozen or damaged.
Patient Advice and Precautions
Patients should be instructed to monitor their blood glucose levels regularly. It's essential to adjust the insulin regimen based on food intake, physical activity, and blood glucose readings. Always rotate injection sites to prevent lipodystrophy. Inform healthcare providers about any changes in health status, as it may require adjustments in insulin therapy. Keep a source of fast-acting sugar on hand to counteract hypoglycemia.